[go: up one dir, main page]

MX2016014991A - Composiciones que contienen acido borico y una mezcla de lactobacilos. - Google Patents

Composiciones que contienen acido borico y una mezcla de lactobacilos.

Info

Publication number
MX2016014991A
MX2016014991A MX2016014991A MX2016014991A MX2016014991A MX 2016014991 A MX2016014991 A MX 2016014991A MX 2016014991 A MX2016014991 A MX 2016014991A MX 2016014991 A MX2016014991 A MX 2016014991A MX 2016014991 A MX2016014991 A MX 2016014991A
Authority
MX
Mexico
Prior art keywords
mixture
boric acid
lactobacillus
containing boric
compositions containing
Prior art date
Application number
MX2016014991A
Other languages
English (en)
Inventor
De Seta Francesco
LEONARDI Lucio
Original Assignee
Pizeta Group Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pizeta Group Srl filed Critical Pizeta Group Srl
Publication of MX2016014991A publication Critical patent/MX2016014991A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a una nueva composición, que contiene ácido bórico y una mezcla de al menos dos lactobacilos seleccionados de L. rhamnosus, L. crispatus, L. jensenhi y L. gasseri. La presente invención se refiere además al uso de la composición anterior en el tratamiento de vulvovaginitis fúngica y/o bacteriana.
MX2016014991A 2014-05-16 2015-05-06 Composiciones que contienen acido borico y una mezcla de lactobacilos. MX2016014991A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20140895 2014-05-16
PCT/IB2015/053300 WO2015173693A1 (en) 2014-05-16 2015-05-06 Compositions containing boric acid and a mixture of lactobacillus

Publications (1)

Publication Number Publication Date
MX2016014991A true MX2016014991A (es) 2017-09-11

Family

ID=51220684

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016014991A MX2016014991A (es) 2014-05-16 2015-05-06 Composiciones que contienen acido borico y una mezcla de lactobacilos.

Country Status (5)

Country Link
US (1) US20170071990A1 (es)
EP (1) EP3142675A1 (es)
BR (1) BR112016026654A2 (es)
MX (1) MX2016014991A (es)
WO (1) WO2015173693A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018013583A2 (en) 2016-07-11 2018-01-18 The Brigham And Women's Hospital, Inc. Medicinal vaginal lactobacillus cocktail
US10258567B1 (en) 2016-11-17 2019-04-16 Grace Procurements Llc Vaginal probiotic products and related processes
US12011469B2 (en) * 2017-05-23 2024-06-18 Vireo Systems, Inc. Parenteral delivery device and methods of use
IT201700062260A1 (it) * 2017-06-07 2018-12-07 Proge Farm Srl Associazione e composizioni topiche cutanee comprendenti lattobacilli e ossidi metallici e/o semimetallici
CN110656060B (zh) * 2019-08-09 2020-08-07 四川厌氧生物科技有限责任公司 多联乳杆菌组合物及其在女性阴道健康中的应用
US11037655B2 (en) 2019-10-16 2021-06-15 University Of Maryland, Baltimore Microbiome-based informed method to formulate live biotherapeutics
US10967012B2 (en) 2019-10-16 2021-04-06 University Of Maryland, Baltimore Microbiome-based informed method to formulate live biotherapeutics
GR20200100043A (el) * 2020-01-29 2021-08-13 ΙΟΥΛΙΑ ΚΑΙ ΕΙΡΗΝΗ ΤΣΕΤΗ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ Α.Β.Ε.Ε., με δ.τ. INTERMED ABEE Συνθεσεις για τοπικη εφαρμογη, που περιεχουν βορικο οξυ και ενα σπορογονο προβιοτικο μιγμα με στελεχη του γενους bacillus, χρησιμες για την αντιμετωπιση των λοιμωξεων και την αποκατασταση της φυσικησχλωριδας του γυναικειου κολπου
JP2023527876A (ja) * 2020-06-01 2023-06-30 フェリング ベスローテン フェンノートシャップ 膣内微生物叢組成物
CN116004465B (zh) * 2023-01-06 2025-03-18 上海上药信谊药厂有限公司 一株格氏乳杆菌及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA39965C2 (uk) * 1993-12-03 2001-07-16 Лайфор Леборетріз Лтд Вірусоцидний, бактерицидний та руйнуючий сперматозоїди вагінальний засіб і вагінальний супозиторій ( варіанти )
WO1997029762A1 (en) * 1996-02-14 1997-08-21 The Procter & Gamble Company Urogenital and intestinal compositions
DK0956858T3 (da) * 1998-04-30 2002-01-28 Vesely Renata Maria Cavaliere Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
US20040071679A1 (en) * 2002-10-15 2004-04-15 Claudio De Simone Identifying and treating vaginal infections
EP2158916A1 (en) * 2008-08-27 2010-03-03 Ellen Aktiebolag Administration unit comprising lactic acid bacteria
EP2428214A1 (en) * 2010-09-14 2012-03-14 HSO Health Care GmbH Compositions for the vaginal and oral administration of lactobacillus and uses thereof

Also Published As

Publication number Publication date
EP3142675A1 (en) 2017-03-22
BR112016026654A2 (pt) 2017-08-15
US20170071990A1 (en) 2017-03-16
WO2015173693A1 (en) 2015-11-19

Similar Documents

Publication Publication Date Title
MX2016014991A (es) Composiciones que contienen acido borico y una mezcla de lactobacilos.
PH12019502279A1 (en) Cleaning compositions and uses thereof
PL3681470T3 (pl) Lactobacillus casei lub lactobacillus paracasei do stosowania w leczeniu infekcji clostridium difficile
WO2018013583A3 (en) Medicinal vaginal lactobacillus cocktail
NZ712959A (en) Probiotic strains for use in treatment or prevention of osteoporosis
WO2016086209A8 (en) Probiotic and prebiotic compositions, and methods of use thereof for treatment of gastrointestinal disorders
PL2937424T3 (pl) Bakteria kwasu mlekowego, kompozycja ją zawierająca i ich zastosowanie
MX2021008318A (es) Nuevos polipeptidos de union especifica y usos de los mismos.
MX2015000338A (es) Novedosa cepa de lactobacillus crispatus.
EP3521415A4 (en) NEW LACTOBACILLUS SAKEI AND COMPOSITION THEREFOR
ZA201804863B (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
SG11201608730UA (en) Bifidobacterium breve cbt br3 strain for promotion of growth and nutraceutical composition for promotion of growth containing the same
TW201613624A (en) Use of lactobacillus reuteri GMNL-263 for manufacturing composition for increasing expression of LDL-R and CYP7A1 in liver in high-fat diet individual
NZ701463A (en) Anti-phytopathogenic composition
MX2019005535A (es) Streptococcus thermophilus para uso en la preparación de productos fermentados.
EP3165599A4 (en) Novel lactic acid bacterium and composition including said lactic acid bacterium
GEP20207089B (en) Histamine-producing bacterial strains and their use in cancer
MX383473B (es) Empleo de probióticos en el incremento de la fertilidad masculina.
IN2013MU02316A (es)
CA2913067C (fr) Utilisation d'une bacterie isolee du genre pseudoalteromonas, cyclolipopeptides et leurs utilisations
IL260181B (en) Preparations and methods for using new strains of Lactobacillus fermentum
PL3168292T3 (pl) Nowy szczep Lactobacillus plantarum AMT14 i kompozycja zawierająca szczep Lactobacillus plantarum AMT14
GB2524474B (en) Composition and use of lactobacillus reuteri GMNL-89 in treating type 2 diabetes
MX2020007906A (es) Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas.
AU2019263623A8 (en) Probiotic Bifidobacterium breve strain and compositions comprising said strain